Cumberland Pharmaceuticals Inc.

$CPIX surged yesterday and is continuing its move up today and leading the Prism MarketView Pharmaceuticals index. Yesterday they announced positive top-line results from its Phase 2 FIGHT DMD trial.

Share this article:

About the Author:

Cumberland Pharmaceuticals Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup